Transdermal Tulobuterol Patch, a Long-Acting β2-Agonist

Comparative Study of Skin Permeation Profiles between Brand and Generic Tulobuterol Patches

(2010) Shigemi Yoshihara et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

COMPARISON OF ADHERENCE AND EFFICACY BETWEEN INHALED SALMETEROL AND TRANSDERMAL TULOBUTEROL PATCH IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDER

(2009) Tomonori Sugawara et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD

(2009) Masakazu Ichinose et al.   RESPIRATORY MEDICINE

Tulobuterol Patch Maintains Diaphragm Muscle Contractility for Over Twenty-four Hours in a Mouse Model of Sepsis

(2009) Chiyohiko Shindoh et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Effects of the Addition of Beta2-agonist Tulobuterol Patches to Inhaled Corticosteroid in Patients with Asthma

(2009) Soichiro Hozawa et al.   ALLERGOLOGY INTERNATIONAL

Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline

(2008) Shuwa Minami et al.   INTERNAL MEDICINE

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

(2008) Donald P. Tashkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease

(2008) Masashi Kanehara et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Comparison of bronchodilatory properties of transdermal and inhaled long-acting β2-agonists

(2007) T. Yamagata et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS